Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression.

Translational psychiatry

Volumn 3, Issue , 2013, Pages

  Winner, J ^a   Allen, J D ^b   Altar, C Anthony ^b   Spahic Mihajlovic, A ^b  

^a AssureRx HealthInc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOCHROME P450; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN;

ADULT; ANALYSIS OF VARIANCE; ANXIETY DISORDER; ARTICLE; DEPRESSION; ECONOMICS; GENETICS; HEALTH CARE PLANNING; HUMAN; INAPPROPRIATE PRESCRIBING; MIDDLE AGED; PHARMACOGENETICS; RETROSPECTIVE STUDY; UTILIZATION REVIEW;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; CYTOCHROME P-450 ENZYME SYSTEM; DEPRESSIVE DISORDER; HEALTH RESOURCES; HUMANS; INAPPROPRIATE PRESCRIBING; MIDDLE AGED; PHARMACOGENETICS; RECEPTOR, SEROTONIN, 5-HT2A; RETROSPECTIVE STUDIES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84880452154     PISSN: None     EISSN: 21583188     Source Type: None    
DOI: 10.1038/tp.2013.2     Document Type: Article

References (0)